These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 29318598)
1. Efficacy and safety of noncultured melanocyte-keratinocyte transplant procedure for vitiligo and other leukodermas: a critical analysis of the evidence. Vakharia PP; Lee DE; Khachemoune A Int J Dermatol; 2018 Jul; 57(7):770-775. PubMed ID: 29318598 [TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of patients undergoing autologous noncultured melanocyte-keratinocyte transplantation for vitiligo and other leukodermas. Silpa-Archa N; Griffith JL; Huggins RH; Henderson MD; Kerr HA; Jacobsen G; Mulekar SV; Lim HW; Hamzavi IH J Am Acad Dermatol; 2017 Aug; 77(2):318-327. PubMed ID: 28502377 [TBL] [Abstract][Full Text] [Related]
3. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios. Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485 [TBL] [Abstract][Full Text] [Related]
4. Melanocyte-keratinocyte transplantation procedure in the treatment of vitiligo: the experience of an academic medical center in the United States. Huggins RH; Henderson MD; Mulekar SV; Ozog DM; Kerr HA; Jabobsen G; Lim HW; Hamzavi IH J Am Acad Dermatol; 2012 May; 66(5):785-93. PubMed ID: 21864935 [TBL] [Abstract][Full Text] [Related]
5. Uncommon responses of segmental vitiligo to melanocyte-keratinocyte transplantation procedure. Isedeh P; Al Issa A; Lim HW; Mulekar SS; Mulekar SV J Cutan Med Surg; 2015; 19(2):177-81. PubMed ID: 25775633 [TBL] [Abstract][Full Text] [Related]
6. Recipient-to-Donor Ratios in the Surgical Treatment of Vitiligo, Leukoderma, and Piebaldism: A Retrospective Review. Maghfour J; Bardhi R; Huggins R; Hamzavi IH; Mohammad TF Dermatology; 2023; 239(5):828-831. PubMed ID: 37231873 [TBL] [Abstract][Full Text] [Related]
7. A retrospective study of long term follow-up of 2283 vitiligo patients treated by autologous, non-cultured melanocyte-keratinocyte transplantation. Zhang D; Wei X; Hong W; Fu L; Qian G; Xu AE Aging (Albany NY); 2021 Feb; 13(4):5415-5425. PubMed ID: 33582653 [TBL] [Abstract][Full Text] [Related]
8. Genital vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation. Mulekar SV; Al Issa A; Al Eisa A; Asaad M Dermatol Surg; 2005 Dec; 31(12):1737-9; discussion 1740. PubMed ID: 16336903 [TBL] [Abstract][Full Text] [Related]
9. Lesional CD8+ T-Cell Number Predicts Surgical Outcomes of Melanocyte-Keratinocyte Transplantation Surgery for Vitiligo. Refat MA; Strassner JP; Frisoli ML; Rashighi M; Richmond J; Nada E; Saleh R; El-Hamd MA; Goldberg D; Mahmoud BH; Harris JE J Invest Dermatol; 2023 Nov; 143(11):2275-2282.e6. PubMed ID: 37478900 [TBL] [Abstract][Full Text] [Related]
10. Practical guidelines for the treatment of vitiligo with the melanocyte-keratinocyte transplantation procedure. Yousif J; Ceresnie MS; Hamzavi IH; Mohammad TF Arch Dermatol Res; 2023 Dec; 316(1):10. PubMed ID: 38038734 [TBL] [Abstract][Full Text] [Related]
12. Outcomes of autologous non-cultured melanocyte keratinocyte transplantation in vitiligo and nevus depigmentosus. Sritanyarat T; Wongpraparut C; Jansuwan N; Yothachai P; Nuntawisuttiwong N; Silpa-Archa N J Dermatolog Treat; 2022 Mar; 33(2):935-940. PubMed ID: 32643482 [TBL] [Abstract][Full Text] [Related]
13. Micropunch grafting as an adjuvant for noncultured melanocyte-keratinocyte transplantation for refractory vitiligo. Bae JM; Ju HJ; Lee RW; Lee HN; Kim NB; Kim YH; Jung HM J Am Acad Dermatol; 2020 Jun; 82(6):1548-1550. PubMed ID: 32160974 [No Abstract] [Full Text] [Related]
14. Vitiligo surgical, laser, and alternative therapies: a review and case series. Wassef C; Lombardi A; Khokher S; Rao BK J Drugs Dermatol; 2013 Jun; 12(6):685-91. PubMed ID: 23839187 [TBL] [Abstract][Full Text] [Related]
15. Recipient site preparation by cryoblebbing in melanocyte keratinocyte transplantation procedure over the fingers in vitiligo: A pilot study. El Hawary M; Bassiouny DA; Esmat S; Sobhi R; Saleh MA; AbdelHalim D; Hegazy R; Gawdat H; Ragab N; Samir N; Sany I Dermatol Ther; 2020 Nov; 33(6):e14199. PubMed ID: 32798282 [TBL] [Abstract][Full Text] [Related]
16. Autologous, Noncultured Epidermal Cell Suspension Grafting in the Management of Mechanically and Chemically Induced Leukodermic Scars. Vyas NS; Lawrence KL; Griffith JL; Hamzavi IH J Cutan Med Surg; 2015; 19(5):488-93. PubMed ID: 25851083 [TBL] [Abstract][Full Text] [Related]
17. Repigmentation of vitiligo-associated leukotrichia after autologous, non-cultured melanocyte-keratinocyte transplantation. Al Jasser MI; Ghwish B; Al Issa A; Mulekar SV Int J Dermatol; 2013 Nov; 52(11):1383-6. PubMed ID: 23834588 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of treatment response to autologous transplantation of noncultured melanocyte/keratinocyte cell suspension in patients with stable vitiligo. Ramos MG; Ramos DG; Ramos CG An Bras Dermatol; 2017; 92(3):312-318. PubMed ID: 29186240 [TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation. Mulekar SV Arch Dermatol; 2004 Oct; 140(10):1211-5. PubMed ID: 15492183 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of traditional and surgical treatment modalities in segmental vitiligo: A review article. Khalili M; Amiri R; Mohammadi S; Iranmanesh B; Aflatoonian M J Cosmet Dermatol; 2022 Jun; 21(6):2360-2373. PubMed ID: 35253324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]